Cite this article as: Saito A, Kumamaru H, Ono M, Miyata H, Motomura N. Propensity-matched analysis of a side-clamp versus an anastomosis assist device in cases of isolated coronary artery bypass grafting. Eur J Cardiothorac Surg 2018;54:889-95. Propensity-matched analysis of a side-clamp versus an anastomosis assist device in cases of isolated coronary artery bypass grafting † Abstract OBJECTIVES: The use of an anastomosis assist device during coronary artery bypass grafting (CABG) is considered less invasive for the ascending aorta than the use of a side-biting clamp (Side-clamp) and to possibly be associated with a lower incidence of postoperative stroke. However, this benefit has not yet been clearly demonstrated. This study was to evaluate whether the use of an anastomosis assist device will minimize the postoperative stroke and other complications in patients undergoing off-pump CABG in comparison with the use of the Side-clamp.
INTRODUCTION
The manipulation of the ascending aorta during coronary artery bypass grafting (CABG) may result in various postoperative complications, such as stroke. The postoperative impact of a variety of aortic manipulations during CABG, for example the use of a sidebiting clamp (Side-clamp), the use of an anastomosis assist device, the aorta no-touch technique and the use of cardiopulmonary bypass with arterial cannulation to the ascending aorta, has been evaluated in previous studies. Although cerebrovascular events have frequently among major postoperative complications, the discussion has not reached a conclusion [1] [2] [3] , and the efficacy of the use of an anastomosis assist device in comparison to a sidebiting clamp has not been adequately evaluated to date. This study evaluated the incidence of perioperative complications with stroke after off-pump CABG (OPCAB) as the primary end point. This was achieved by utilizing the nationwide Japan Adult Cardiovascular Surgery Database (JCVSD). A propensity-matched analysis was performed to compare the short-term outcomes of OPCAB procedures performed using the Side-clamp with those performed using an anastomosis assist device, in order to justify the use of an anastomosis assist device in the treatment of our patients.
METHODS

Japan Adult Cardiovascular Surgery Database
JCVSD is a nationwide registry of patients undergoing cardiovascular surgery in Japan. Data collection was conducted using the National Clinical Database and was linked to cardiovascular †Presented at the 31st Annual Meeting of the European Association for CardioThoracic Surgery, Vienna, Austria, 7-11 October 2017. surgery certification. Data from 590 cardiac surgery units located throughout Japan (close to 100% of the total number of such units) were recorded in the JCVSD adult section registry between January 2013 and December 2016. The methods of data collection and the data content of the JCVSD adult section have been previously described [4, 5] . The data registration project was approved by the institutional review board of the Japanese Surgical Society. The JCVSD variables and the relevant definitions (available online at http://jacvsd.umin.jp) were identical-for the most part-to those of the Society of Thoracic Surgeons (STS) National Adult Cardiac Database (available online at http://sts. org), with some modifications. Most of the data components collected in the database are required data components (i.e. the system forbids registration unless data are entered). As this study utilized only these main data components, almost no records were missing data. A limited number of cases [184 out of 56 102 isolated CABGs (0.3%)] that lacked information on the patients' age, sex or 30-day postoperative status, which we believe arose from a system error, were deleted from the database.
Study population
Data on the patients who underwent isolated OPCAB using either the Side-clamp or an anastomosis assist device (i.e. HEARTSTRING, ENCLOSE II or PAS-PORT) in the years 2013-2016 and who were registered in the JCVSD were extracted from the database. The patients who underwent conversion to open-heart surgery as well as those without ascending aortic manipulation were excluded from this study (Fig. 1 ).
Study outcome
As the primary outcome, we assessed the incidence of postoperative stroke within 30 days after the surgery or during hospitalization. Stroke was defined in the registry as 'cerebrovascular events with paralytic symptoms relevant to central nervous system persisting for more than 72 h during hospitalization'. As secondary outcomes, we assessed the rates of all-cause postoperative 30-day death, all-cause surgical death (death within 30 days or during the same hospitalization), transient neurological complications [transient ischaemic attack, reversible ischaemic neurological deficit or delirium], renal failure with a serum creatinine level of >2.0 mg/dl plus twice the level of preoperative serum creatinine, newly initiated dialysis, new-onset atrial fibrillation (AF) requiring any intervention, prolonged ventilation lasting >72 h, deep sternal infection (with infection penetrating the mediastinal cavity requiring debridement/drainage, with a positive culture, or for which antibiotics were administered), or reoperation for bleeding or graft occlusion. Complications that occurred within 30 days of surgery or during hospitalization were recorded in the database. We also assessed the operative time.
Patient and procedural characteristics
We extracted the information on patient characteristics and procedural characteristics which we considered to be associated with the outcomes, as well as those potentially affecting the surgeon's choice between an anastomosis assist device or the Sideclamp, from the database. These included age, sex, body mass index, smoking status, comorbidities (diabetes mellitus, renal dysfunction, chronic dialysis, hyperlipidaemia, hypertension, carotid artery disease, chronic occlusive pulmonary disease, thoracic aortic disease, peripheral artery disease, congestive heart failure, history of cerebrovascular accident, past percutaneous coronary intervention and past CABG), preoperative conditions (presentation: acute myocardial infarction, angina, asymptomatic ischaemia, old myocardial infarction, other, presence of cardiac shock, New York Heart Association classification, left ventricular function and presence of mitral insufficiency), preoperative medication use [digitalis, beta blockers, acetylsalicylic acid (ASA), non-ASA antiplatelets, warfarin, direct oral anticoagulants, other anticoagulants and steroids] and procedural characteristics (urgency of surgery, whether or not a preoperative catheter examination was conducted, number of stenotic vessels, presence of left main trunk stenosis, use of the bilateral internal thoracic arteries and number of anastomoses). The patients were given ASA within 5 days before surgery.
Statistical analysis
We tabulated the patient characteristics by the method of aortic manipulation (i.e. Side-clamp or an anastomosis assist device), the number and percentage for categorical variables, and the mean and standard deviation for age. The characteristics were compared between the 2 groups using standardized mean differences, which were calculated using the SAS macro published by Yang and Dalton [6] . We estimated the propensity score (PS) for the use of an anastomosis assist device against the use of the Side-clamp for each patient, by fitting a logistic regression model with all of the above-mentioned patient and procedural characteristics. Then, using the SAS macro provided by Coca-Perraillon [7] , we conducted greedy nearest neighbour matching between the 2 groups, with a caliper of 0.2 SD of the logit (PS). We checked the balance of the patient and procedural characteristics of the matched cohort using the above-described method.
We compared the incidence of the study end points between the matched Side-clamp and Device patients using the McNemar's test and Wilcoxon Signed-rank test for paired samples for binary outcomes and continuous outcomes, respectively. All of the statistical tests were 2-tailed, and P-values of <0.05 were considered to indicate statistical significance. All analyses were conducted using SAS 9.4 (SAS Institute Inc., Cary, NC, USA).
RESULTS
A total of 33 407 patients who underwent OPCAB during the study period in the JCVSD were identified. After excluding those who did not meet the inclusion criteria, data on 7374 patients and 14 213 patients who underwent OPCAB using the Side-clamp or an anastomosis assist device, respectively, were extracted from the database.
Patient procedural characteristics
In general, the patient and procedural characteristics of the 2 groups were similar, with a few exceptions ( Table 1 ). In the Device group, the age of the patients was slightly older [mean age (standard deviation); Side-clamp 69.1 (9.8) years; Device 70.2 (9.4)], and the frequency of patients with a history of smoking was higher (Side-clamp 48.6%; Device 53.4%). The incidence of carotid artery disease in the patients in the Device group (9.6%) was higher than that in the patients in the Side-clamp group (7.1%). The frequency of procedures to treat old myocardial infarction was slightly higher in the Side-clamp group. The use of ASA and non-ASA antiplatelet therapy was higher among patients in the Side-clamp group, whereas anticoagulant use was higher among the patients in the Device group. A higher percentage of the patients in the Side-clamp group underwent a larger number (>3) of anastomoses. All other characteristics were similar between the 2 groups with a standardized difference of <0.07.
The propensity score distribution and balance of characteristics in the matched cohort
The c-statistic of the PS model was 0.602. As expected, there was a large amount of overlap in the distribution of the PSs between the 2 groups before matching (Fig. 2) . We matched 7348 Sideclamp and 7348 Device patients based on their PSs. The distribution of the PS values of the 2 groups were almost completely identical in the matched cohort (Fig. 2) . The balance of the patient and procedural characteristics between the 2 groups was further improved, with a standardized mean difference of <0.03 for all variables.
Short-term clinical results
The short-term postoperative outcomes in the matched cohort are presented in Table 2 . The incidence of the primary outcome of stroke was similar in the 2 groups, with 99 (1.4%) patients in the Side-clamp group and 89 (1.2%) patients in the Device group (P = 0.46). The rates of 30-day and operative mortality were also similar in the 2 groups (operative mortality: Side-clamp 1.4%; Device 1.5%; P = 0.78). The incidence of major complications [operative death, stroke, newly initiated dialysis, prolonged ventilation (>24 h) due to pulmonary complications, deep sternal wound infection and reoperation for bleeding] did not differ to a statistically significant extent (Side-clamp 7.0%; Device 7.5%; P = 0.23). With regard to the postoperative morbidities, significant differences were observed in the incidence of transient ischaemic attack/reversible ischaemic neurological deficit/delirium [Sideclamp n = 93 (1.3%); Device n = 64 (0.9%); P = 0.020], new-onset AF [Side-clamp n = 807 (11.0%); Device n = 943 (12.8%); P <0.001] and prolonged ventilation [Side-clamp n = 147 (2%); Device n = 212 (2.9%); P < 0.001). The overall length of intensive care unit (ICU) stay was similar. With regard to the procedural results, the patients in the Device required homologous blood transfusion more frequently than those in the Side-clamp group (Side-clamp 54.6%; Device 60.0%; P < 0.001), and the average operation time was significantly shorter in the Side-clamp group [mean (standard deviation); Side-clamp 304.5 (99.5) min; Device 319.5 (97.9) min]. The days in the ICU were very similar between the 2 groups but were found to be marginally shorter for the Side-clamp group (median days in ICU: 3 days for Side-clamp, 3 days for Device, P-value 0.036).
DISCUSSION
During CABG, the manipulation of the ascending aorta, for which various degrees of invasive manipulation have been conceived, is often thought to increase the risk of postoperative cerebrovascular events. These include arterial cannulation for the establishment of cardiopulmonary bypass, the use of cross clamping, the use of Side-clamps and the use of anastomosis assist devices. The risks associated with the above-mentioned manipulations have been investigated in a series of studies [1-3, 8, 9] . In addition, the efficacy of the aorta no-touch technique has also been discussed previously [10] [11] [12] . In this study, we focused on the benefit of using an anastomosis assist device in reducing postoperative cerebrovascular events, especially stroke; however, at the time of writing, a consensus has not been reached with regard to the efficacy of anastomosis assist devices in this respect [1, [12] [13] [14] [15] [16] [17] [18] . The current study question originally arose from a previous report [13] , in which we hypothesized that the frequent use of anastomosis assist devices might be effective for reducing postoperative cerebrovascular complications. As 60% of CABG procedures are performed in an off-pump manner, and given the fact that anastomosis assist devices such as the HEARTSTRING, ENCLOSE II and PAS-PORT systems are frequently used in Japan, a rigorous comparison focusing on the differences between the impact of Side-clamp and anastomosis assist device use in the ascending aorta has become possible.
To the best of our knowledge, this is the largest clinical study to investigate the effect of anastomosis assist devices in OPCAB cases. A significant majority of the cases were included in the analysis (7348 of the 7374 Side-clamp cases and 7348 of the 14 213 Device cases after stratification), supporting the overall reliability of the results that were obtained. The overall background factors were well balanced, because the estimated rates of mortality and morbidity were similar between the 2 groups.
This study sought to quantify the protective effect of anastomosis assist device use, as an emerging technique (second in efficacy to the aorta no-touch method) in combatting postoperative cerebrovascular events to improve postoperative complications; several favourable clinical outcomes have been published in the past [1, 2, [12] [13] [14] [15] [16] [19] [20] [21] [22] [23] [24] [25] [26] . The benefit of the aorta no-touch technique is an accepted issue today; thus, to make the comparison as simple and straightforward as possible, we only compared the Side-clamp and Device groups. Our expectations were partially met in that the use of an anastomosis assist device provides a benefit in terms of minimizing the incidence of perioperative transient neurological complications with regard to the transient ischaemic attack/reversible ischaemic neurological deficit/delirium; on the other hand, the stroke rate was similar between the 2 groups. This result-with regard to the stroke rate-was compatible with the results of a network metaanalysis reported by Zhao et al [12] . In their report, the use of partial clamping and the use of a HEARTSTRING device were associated with a reduced rate of stroke in comparison with on-pump CABG; however, the comparison between the partial clamp and anastomosis assist device use revealed no significant difference in the stroke rate. There was no clear description regarding the degree of coronary artery disease in the target cohort, and this factor may not have been fully assessed elsewhere in the past. Our database did not record the frequency of the application of clamping manoeuvres in each case, which might have interfered with the outcome regarding the cerebrovascular event rate.
Our results, which showed a higher incidence of new-onset AF and prolonged ventilation in the Device group, also need to be discussed. With regard to the AF, we matched the preoperative characteristics in detail, including ASA and beta-blocker use; thus, it can be stated that the background characteristics of the patient had minimal influence on this result. The notable findings were that the blood transfusion rate was higher and the operation time was longer in the Device group. Bleeding during the procedure might be a serious issue with the use of anastomosis assist devices regarding technical achievement in handling, and this issue has resulted in the higher requirement of homologous blood in the Device group. Although excessive bleeding did not seem to result in the higher requirement of re-exploration, it could be one factor that resulted in the higher incidence of AF in the Device group. In 2014, Alameddine et al. [27] reported that perioperative blood transfusion may be associated with excess AF following CABG and that this risk was associated with the amount of transfusion. Another report from the Cleveland Clinic demonstrated that perioperative red blood cell transfusion is associated with an increased risk of postoperative morbidity after isolated CABG [28] . They did not clearly comment on AF but they noted that red cell transfusion was a significant risk factor for prolonged ventilation (>24 h), and this was compatible with the results of our study.
Limitations
This study was associated with some limitations. Although this study was performed using a national database to provide clinical information on a very high-volume cohort, we could not always obtain data on very specific issues with regard to the use of specific anastomosis assist devices or how they were applied to the aorta, or the degree of aortic disease. Our database is periodically reviewed and updated with more appropriate questionnaires. The newest version of the database (2017) contains information on the status of the aorta, and a further update of this study may provide more relevant results to better address our clinical questions.
Another limitation was the fact that this study primarily focused on the detailed short-term outcomes and did not investigate the long-term results because the data were extracted from clinical results accumulated from 590 cardiac surgical units located throughout Japan. Thus far, the submission of 100% of the data to the JCVSD under third-party surveillance has only been achieved over the short term; however, it is anticipated that this national database will include long-term follow-up data in the future and thereby allow for the analysis of the long-term outcomes.
CONCLUSIONS
In conclusion, when the perioperative characteristics, short-term surgical results and risk profiles for OPCAB, were analysed. The use of an anastomosis assist device provided better outcomes than Side-clamp with respect to minimizing postoperative transient neurological complications but at the same time increased the risk of blood transfusion, new-onset AF and prolonged ventilation, and the overall benefit of using an anastomosis assist device was not demonstrated. Further stratification of the patients, such as by the severity of coronary artery disease, may yield additional information on the patients in whom device use is expected to be beneficial. In the future, it might be also necessary to investigate the economic benefit of device use by balancing the cost of the anastomosis assist device with the extra cost of postoperative complications. Further investigation of the means to reduce the rate of postoperative complications following OPCAB will require the appropriate selection of relevant procedures based on multiple aspects.
